Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA) started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report issued on Saturday. The firm issued a sell rating on the basic materials company’s stock. Separately, HC Wainwright dropped their target price on shares of Arcadia Biosciences from $15.00 to $10.00 and set a buy rating for the company in […]

Leave a Reply

Your email address will not be published.

Previous post New Relic (NYSE:NEWR) Research Coverage Started at
Next post Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)